Stock data
Kiora Pharmaceuticals, Inc. (KPRX)
Kiora Pharmaceuticals, Inc. (KPRX) reported revenue of US$0.00M and net income of -US$10.84M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$12.83M | -US$10.84M | — |
| 2024 | US$16.02M | — | US$4.51M | US$3.59M | — |
| 2023 | US$0.00M | — | -US$12.59M | -US$12.51M | — |
| 2022 | — | — | -US$12.31M | -US$13.58M | — |
| 2021 | US$0.00M | — | -US$14.24M | -US$13.77M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$2.08M | — |
| 2026-03-31 | — | -US$2.42M | — |
| 2025-12-31 | US$0.00M | -US$6.52M | — |
| 2025-09-30 | US$0.00M | US$0.03M | — |
| 2025-06-30 | US$0.00M | -US$2.15M | — |
| 2025-03-31 | US$0.00M | -US$2.19M | — |
| 2024-12-31 | US$0.00M | -US$4.22M | — |
| 2024-09-30 | US$0.00M | -US$3.41M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.